Baxter International Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) was filed by Baxter International Inc. on November 16, 2004, covering events occurring on November 16 and November 18, 2004. The filing addresses corporate governance updates regarding dividend declarations and executive leadership changes.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed is the declaration of a regular annual dividend of $0.582 per share of common stock.
Material Changes
- Dividend Declaration: The Board of Directors declared a regular annual dividend of $0.582 per share, payable on January 5, 2005, to stockholders of record as of December 10, 2004. This represents a continuation of the current annual rate.
- Executive Departure: David F. Drohan, Senior Vice President of Baxter Healthcare Corporation and President of the Medication Delivery business, announced plans to retire in early 2005.
Outlook, Risks, and Management Commentary
Management indicated that Mr. Drohan will remain in his current position until a successor is named to ensure a smooth transition for the Medication Delivery business. The Company has initiated an external search for his successor. No specific risks, contingencies, or unusual items were detailed in this report beyond the standard transition of executive leadership.
Investor Verification Checklist
- Verify the record date of December 10, 2004, and payment date of January 5, 2005, for the $0.582 per share dividend.
- Monitor future announcements regarding the appointment of a successor to David F. Drohan for the Medication Delivery business.
- Review the attached press releases (Exhibits 99.1 and 99.2) for additional context on the dividend and retirement.